Trishna Goswami - Sep 4, 2024 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Sep 4, 2024
Transactions value $
$0
Form type
4
Date filed
9/5/2024, 04:35 PM
Previous filing
Feb 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Employee Stock Option (right to buy) Award $0 +250K $0.00 250K Sep 4, 2024 Common Stock 250K $0.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date.